Aripiprazole augmentation of antidepressants for the treatment of partially responding and nonresponding patients with major depressive disorder.

@article{Simon2005AripiprazoleAO,
  title={Aripiprazole augmentation of antidepressants for the treatment of partially responding and nonresponding patients with major depressive disorder.},
  author={Jeffrey S. Simon and Charles B. Nemeroff},
  journal={The Journal of clinical psychiatry},
  year={2005},
  volume={66 10},
  pages={1216-20}
}
OBJECTIVE To determine the efficacy and tolerability of aripiprazole, a dopamine D2 and 5-HT1A receptor partial agonist, as augmentation of antidepressant treatment of partially responding and nonresponding patients with major depressive disorder. METHOD Fifteen patients with major depressive disorder (diagnosed with a site-generated form described in the text) and an incomplete response or no response to > or = 8 weeks of antidepressant (selective serotonin reuptake inhibitor, venlafaxine… CONTINUE READING